cartouche ECN WORKSHOP
-

Abstracts

2023 - Poster

Therapeutics-Miscellaneous

Treatment of gout patients in seven primary care centers from barcelona

Cesar Diaz-Torne(1), Daniel Martinez-Laguna(2), Raquel Gayarre (3), Meritxell Aivar (4), Jordi Hoyo (5), Angeles Conesa (2), Carlen Reyes (6), Cristina Carbonell (7), Jose Luis Estebanez (8), Maria Antonia Pou (3)

2023 - Oral communication

Therapeutics-Miscellaneous

Factors associated to loss for follow-up in a prospective gout cohort

Fernando Perez-Ruiz, Cristina Vazquez-Puente, Maria Del Consuelo Modesto- Caballero, Ana María Herrero-Beites

2023 - Oral communication

Therapeutics-Miscellaneous

Real-life results of urate-driven pharmacotherapy with three urate lowering drugs in gout: allopurinol, febuxostat and benzbromarone

Hotea I 1,2, Giesen T1, Comarniceanu A 1, Efde M 1, Van Osch F 3, Janssen M 1, Jansen Tltha 1,4.

2023 - Oral communication

Therapeutics-Miscellaneous

Rationale and design for PODAGRA II: a multicenter randomized phase 2/3 study assessing the efficacy and safety of dapansutrile, an orally administered specific inhibitor of the nlrp3 inflammasome in subjects with an acute gout flare

Tim Jansen, Phil Piscitelli, Cynthia Barrow, Kip Vought, Amy Poshusta, Heather Kapushoc, Andrea Leonard-Segal, Mustafa Noor, Damaris Skouras, Charles Dinarello, Naomi Schlesinger

2022 - Oral communication

Therapeutics-Miscellaneous

Can Doctors Treat Gout Well? Insight On Gout Management In Referral Centres

Charlotte Jauffret, Sebastien Ottaviani, Augustin Latourte, Hang Korng Ea, Sahara Graf, Frederic Lioté, Thomas Bardin, Pascal Richette, Tristan Pascart

2023 - Oral communication

Therapeutics-Miscellaneous

Impact of combined intervention with clinical nurse specialist in the management of cardiovascular risk in patients with gout

Calvo-Aranda E, Novella-Navarro M, Angel-Sesmero JA, Cardoso-Peñafiel P, Gomez-Gonzalez CM, Cebrian-Mendez L, Marin-Huertas C, Matias De La Mano Ma, Lojo-Oliveira L, Sanz-Jardon M, Sanchez-Aranda Fm, Navio-Marco MT

2018 - Poster

Therapeutics-Miscellaneous

GOUT AND PARKINSON’S DISEASE IN A MEDITERRANEAN URBAN POPULATION. A CASE-CONTROL STUDY

Francesc Orfila Pernas1,2, Marina Pou Gimenez¹, Cesar Diaz-Torne³, Enrique Calvo Aranda4

2020 - Poster

Therapeutics-Miscellaneous

Key role of the Clinical Nurse Specialist in patients with gout: results of a quality-of-care survey

E. Calvo-Aranda 1, FM. Sanchez-Aranda, L. Cebrian-Mendez, MA. Matias De La Mano, L. Lojo-Oliveira, MT. Navio-Marco

2020 - Poster

Therapeutics-Miscellaneous

HOME-MONITORING GOUT FLARES WITH A SMARTPHONE APP RESULTS OF A FEASIBILITY STUDY

Bph. Pouls 1,2, Cl. Bekker 2, Bjf. Van Den Bemt 1,2, Al. Gaffo 3, M. Flendrie 1

2021 - Oral communication

Therapeutics-Miscellaneous

MICROGLIA CONTROL SMALL VESSEL CALCIFICATION VIA TREM2

Yvette Zarb(1) , Sina Nassiri(2), Sebastian Guido Utz(3), Johanna Schaffenrath(1), Mauro Delorenzi(2), Marco Colonna(4), Melanie Greter(3), Annika Keller(1)

2015 - Poster

Therapeutics-Miscellaneous

Serum magnesium levels in patients in relation to diuretic treatment

Irati Urionagüena, Sandra P. Chinchilla, Fernando Perez-Ruiz.

2021 - Oral communication

Therapeutics-Miscellaneous

A precise identification of crystal deposits in the kidney tissue

Frochot V, Jouanneau C, Letavernier E, Haymann JPh, Bazin D, Daudon M.